American Society of Hematology, Blood, 7(123), p. 952-953, 2014
DOI: 10.1182/blood-2013-12-542480
Full text: Download
In this issue of Blood, Hoellenriegel et al provide evidence that NOX-A12, an RNA oligonucleotide able to bind and neutralize CXCL12, effectively interferes with chronic lymphocytic leukemia (CLL) cell chemotaxis and stroma-mediated drug-resistance.1